Company / Revenue
RELMADA THERAPEUTICS, INC. Revenue History
FY2013-FY2013 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$7.9K
FY2013
5-year range
$7.9K / $7.9K
FY2013-FY2013
Trend
-
vs FY2012
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$7,941 in FY2013.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2013 | $7.9K | - |
As of FY2013 · SEC 10-K · Updated Jun 28, 2026